$Travere Therapeutic (TVTX.US)$ NEWS Travere Therapeutics to...
NEWS
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
Travere Therapeutics to present data on FILSPARI at prestigious medical conferences, demonstrating the potential superiority of FILSPARI over existing treatments
Analyses show FILSPARI's ability to slow kidney function decline in patients with IgA nephropathy, offering a new approach to patient care
New 48-week findings from the SPARTAN Study reveal FILSPARI's effectiveness as a first-line treatment for IgA nephropathy patients, earning recognition as a top-rated abstract
Travere Therapeutics to present data on FILSPARI at prestigious medical conferences, demonstrating the potential superiority of FILSPARI over existing treatments
Analyses show FILSPARI's ability to slow kidney function decline in patients with IgA nephropathy, offering a new approach to patient care
New 48-week findings from the SPARTAN Study reveal FILSPARI's effectiveness as a first-line treatment for IgA nephropathy patients, earning recognition as a top-rated abstract
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment